EY Life Sciences. Key themes from The Next Frontiers in Precision Medicine panel. February 2016

Transcription

1 EY Life Sciences Key themes from The Next Frontiers in Precision Medicine panel February 2016

2 Evolution of precision medicine One-size-fits-all therapeutics Precision medicine Disconnected health care Connected health care Convergence of Tx, Dx and consumer creating new vision of the super health care consumer Sick-care Well-care Page 2 Presentation title

3 The next frontiers in precision medicine: key themes 1 Convergence of therapeutics, diagnostics and consumerism in the life sciences industry is here to stay. 2 Development of creative commercial strategy and M&A strategy is imperative to drive success. 3 The scientific and clinical underpinnings of these convergence plays drive their real value. 4 Strong diligence must be performed to be sure to cut through all of the hype and choose the real winners in the space. Page 3

4 EY Life Sciences We work with a broad spectrum of life sciences companies to meet business needs, from strategy to deal execution. Our professionals have deep clinical, scientific and consulting experience in the following areas: Pharma and biotech Diagnostics Medical device Life science tools Information technology R&D In vitro Cardiovascular Cell biology Health IT Drug delivery Anatomical path GI/urology Laboratory animals Bioinformatics Marketing/brand management Medical advisory Commercial LCM Managed markets Specialty pharma Distribution Clinical chem Immunoassay Microbiology Molecular Point-of-care In vivo Reference/specialty labs Hospital supplies Imaging Neurology Orthopedics Patient monitoring Respiratory Surgical equipment Wound care Mass spec Microarray Microscopy PCR Proteomics Sample prep Separations Sequencing Data analytics Data management and storage LIMS Algorithm development App development Connected health Disease areas Cardiovascular CNS Dermatology Endocrinology GI Hematology Immunology Infectious disease Nephrology Obesity Oncology Ophthalmology Orphan Orthopedics Pain Psychiatry Respiratory Rheumatology Urology Vaccines Women s health Page 4

5 Key contacts Kristin Ciriello Pothier Head of Life Sciences, Parthenon-EY Transaction Advisory Services John L. Babitt Life Sciences Financial Diligence and Medtech Leader Transaction Advisory Services, Scott Palmer Precision Medicine Leader, Parthenon-EY Transactions Advisory Services Mahala Burn Life Sciences Practice Director, Parthenon-EY Transaction Advisory Services, Page 5

6 EY Assurance Tax Transactions Advisory About EY EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities. EY refers to the global organization and may refer to one or more of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. For more information about our organization, please visit ey.com. is a client-serving member firm of Ernst & Young Global Limited operating in the US All Rights Reserved. ED None This material has been prepared for general informational purposes only and is not intended to be relied upon as accounting, tax or other professional advice. Please refer to your advisors for specific advice. ey.com